Internal Medicine, Pulmonary Disease · Gallipolis, OH
NPI
1770534497
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
100 Jackson Pike
Gallipolis, OH, 45631
Phone (740) 446-5002
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
1,621 services
Medicare patients, 2024
656
Average age 72
Drug cost, 2024
$1.2M
4,943 prescriptions
Company payments, 2025
$1,142
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Santpal S Mavi was code 99214 (office e&m - established), 605 times for 410 patients. In total Santpal S Mavi billed 1,621 services in 23 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 605 | 410 | $66.56 | $40K |
| 94060 Pulmonary Function Testing | Facility | 229 | 224 | $7.32 | $1,675 |
| 94726 Pulmonary Function Testing | Facility | 229 | 224 | $8.46 | $1,937 |
| 94729 Pulmonary Function Testing | Facility | 229 | 224 | $6.34 | $1,452 |
| 99204 Office E&M - New | Facility | 100 | 100 | $93.48 | $9,348 |
| 99214 Office E&M - Established | Office | 94 | 82 | $52.25 | $4,911 |
| 95810 Sleep Study | Office | 39 | 39 | $69.16 | $2,697 |
| 94010 Pulmonary Function Testing | Facility | 29 | 13 | $6.23 | $181 |
| 95800 Sleep Study | Office | 15 | 15 | $25.03 | $375 |
By year: 2022 $137K for 2,563 services; 2023 $101K for 2,136 services; 2024 $65K for 1,621 services.
Medicare prescription drug claims, 2024
In 2024, the drug Santpal S Mavi prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,004 prescriptions and refills. In total Santpal S Mavi wrote 4,943 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,004 | 1,259 | 310 | $24K |
| Montelukast Sodium Generic | 717 | 1,267 | 186 | $4,890 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 459 | 555 | 107 | $348K |
| Spiriva Respimat Tiotropium Bromide | 304 | 385 | 73 | $199K |
| Fluticasone Propionate Generic | 288 | 608 | 123 | $3,670 |
| Breo Ellipta Fluticasone/Vilanterol | 228 | 300 | 49 | $115K |
| Levocetirizine Dihydrochloride Generic | 202 | 265 | 51 | $1,602 |
| Symbicort Budesonide/Formoterol Fumarate | 187 | 291 | 69 | $66K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 168 | 240 | 54 | $22K |
| Ventolin Hfa Albuterol Sulfate | 161 | 213 | 55 | $12K |
| Spiriva Handihaler Tiotropium Bromide | 160 | 226 | 32 | $110K |
| Advair Hfa Fluticasone Propion/Salmeterol | 137 | 167 | 32 | $52K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 118 | 134 | 43 | $15K |
| Incruse Ellipta Umeclidinium Bromide | 97 | 129 | 33 | $43K |
| Breyna Budesonide/Formoterol Fumarate | 85 | 102 | 31 | $12K |
Brand drugs: 2,552 claims; generic drugs: 2,391 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Santpal S Mavi $1,142 ($1,142 in general payments such as food, travel and fees) from 19 companies. The largest payer was Viatris Specialty LLC with $246.
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 12 | $246 |
| Verona Pharma, Inc. VRNA | 6 | $153 |
| Genzyme Corporation SNY | 5 | $113 |
| Insmed, Inc. INSM | 3 | $86.37 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $83.02 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $75.88 |
| Baxter Healthcare BAX | 4 | $72.41 |
| Novo Nordisk Inc NVO | 3 | $58.77 |
| Lilly USA, LLC LLY | 1 | $45 |
| Merck Sharp & Dohme LLC MRK | 2 | $38.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.